Ironwood Pharmaceuticals (IRWD) Other financing activities (2010 - 2025)
Ironwood Pharmaceuticals (IRWD) posted Other financing activities of $122000.0 for Q4 2025, up 38.64% sequentially from $88000.0 in Q2 2025, and down 39.9% YoY from $203000.0 in Q4 2024.
Ironwood Pharmaceuticals (IRWD) Other financing activities (2010 - 2025) Analysis & Trends
Ironwood Pharmaceuticals has reported Other financing activities for 16 years, with the latest figure at $122000.0 in Q4 2025.
- Quarterly Other financing activities fell 39.9% year-over-year to $122000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $216000.0 (down 98.04% YoY) and the FY2025 annual result came in at $216000.0, down 98.04% from the prior year.
- Other financing activities climbed to $122000.0 in Q4 2025 per IRWD's latest filing, from $88000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $10.1 million in Q1 2024 and troughed at $6000.0 in Q1 2025.
- A 5-year average of $2.6 million and a median of $1.5 million in 2022 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2021 and 2025: Other financing activities soared 820.0% in 2021, then slumped 99.94% in 2025.
- Over 5 years, Other financing activities stood at $5.5 million in 2021, then tumbled by 49.39% to $2.8 million in 2022, then tumbled by 64.43% to $998000.0 in 2023, then slumped by 79.66% to $203000.0 in 2024, then slumped by 39.9% to $122000.0 in 2025.
- According to Business Quant data, Other financing activities over the past three periods registered $122000.0, $88000.0, and $6000.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Ironwood Pharmaceuticals | 706.94 Mn | 627.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 122,000.00 |
| Dec 31, 2025 | 122,000.00 |
| Jun 30, 2025 | 88,000.00 |
| Jun 30, 2025 | 88,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 203,000.00 |
| Dec 31, 2024 | 203,000.00 |
| Jun 30, 2024 | 749,000.00 |
| Jun 30, 2024 | 749,000.00 |
| Mar 31, 2024 | 10.06 Mn |
| Mar 31, 2024 | 10.06 Mn |
| Dec 31, 2023 | 998,000.00 |
| Dec 31, 2023 | 998,000.00 |
| Sep 30, 2023 | 12,000.00 |
| Sep 30, 2023 | 12,000.00 |
| Jun 30, 2023 | 1.37 Mn |
| Jun 30, 2023 | 1.37 Mn |
| Mar 31, 2023 | 3.98 Mn |
| Mar 31, 2023 | 3.98 Mn |